Pharmagreen Biotech Inc.
PHBI · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -47.4% | -23.1% | 65.3% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -383.6% | 41.4% | 44.6% | 25.1% |
| EBITDA | $0 | -$0 | $1 | -$1 |
| % Margin | 16,655.2% | -19,786.8% | 77,488.3% | -153,843.9% |
| Net Income | $0 | -$0 | $1 | -$1 |
| % Margin | 13,606.6% | -21,063.7% | 76,484.2% | -155,503.2% |
| EPS Diluted | 0 | -0 | 0.001 | -0.001 |
| % Growth | 150% | -120% | 183.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |